Page last updated: 2024-11-04

sevoflurane and ER-Negative PR-Negative HER2-Negative Breast Cancer

sevoflurane has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"(1) Background: Triple negative breast cancer (TNBC) is a highly aggressive tumor, associated with high rates of early distant recurrence and short survival times, and treatment may require surgery, and thus anesthesia."1.62Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study. ( Grigoras, I; Patrașcanu, E; Postu, PA; Tiron, A; Tiron, CE; Vacarean Trandafir, IC, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tiron, CE1
Patrașcanu, E1
Postu, PA1
Vacarean Trandafir, IC1
Tiron, A1
Grigoras, I1

Other Studies

1 other study available for sevoflurane and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study.
    Current issues in molecular biology, 2021, Jun-02, Volume: 43, Issue:1

    Topics: Anesthetics, Inhalation; Cell Culture Techniques, Three Dimensional; Cell Line; Cell Line, Tumor; Ce

2021